Hi all,
Would somebody please help me with the English?
Regards,

Fizzi

Dear Dr______ _________,

I would like to invite you to participate in comparative research on the quality of pharmaceutical information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). You were selected at random to participate in this survey.

Your participation in the survey is very important but it is strictly voluntary and you may withdraw from the research at anytime. The result of this study will be a part of the thesis to be submitted as a requirement for the degree of Doctor of Philosophy, University of X.

The purpose of this comparative study is to determine the quality of information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). This study is done with the aim to improve the quality of information provide by pharmaceutical industry to doctors.

If you accept to participate to this study, you will need to evaluate pharmaceutical information given in a presentation by pharmaceutical representative. Following each sales visit you have to fill out a questionnaire focusing only on the main product or claim discussed in the discussion. No attempt will be made to influence pharmaceutical representatives and doctors discussion.

As an attempt to evaluate the actual practice of pharmaceutical representatives, informed consent will not be obtained from them. You will need to advise them that their visit could be monitored for the purpose of a study on the quality of information provided to doctors. No data will be collected on identities of pharmaceutical representatives and doctors.

Pharmaceutical representatives will be informed by a leaflet of the details of the study such as does not include any recording (audio or videotape of the visits). They will not be told if their personal meeting will be monitored and will be assured that all identifying data on pharmaceutical representatives and doctors would be kept strictly confidential.

Another part of the research, you will need to collect all research articles and printed material (e.g. pamphlets, detailing card) for further investigation.

All information collected as part of the study will be retained for seven years. Information will be kept electronically and also in hand-written notes. All records containing personal information will remain confidential and no information which could lead to identification of any individual will be released.

Please do not hesitate to contact me if you need any further information.

Yours sincerely,
Dear Dr______ _________,

I would like to invite you to participate in comparative research on the quality of pharmaceutical information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). You were selected at random to participate in this survey.

Your participation in the survey is very important but it is strictly voluntary and you may withdraw from the research at any time. The result of this study will form be a part of a thesis to be submitted as a requirement for the degree of Doctor of Philosophy, University of X.

The purpose of this comparative study is to determine the quality of information provided by pharmaceutical representatives to doctors in (country 1) and (country 2). This study is done with the aim of improving the quality of information provide by pharmaceutical industry to doctors.

If you agree to participate in this study, you will need to evaluate pharmaceutical information given in presentations by pharmaceutical representatives. Following each sales visit you will have to fill out a questionnaire focusing only on the main product or claim discussed. in the discussion. We will not attempt to influence these discussions.

As an attempt to evaluate the actual practice of pharmaceutical representatives, informed consent will not be obtained from them. You will need to advise them that their visit could be monitored for the purpose of a study on the quality of information provided to doctors. No data will be collected on identities of pharmaceutical representatives and doctors.

Pharmaceutical representatives will be informed by a leaflet of the details of the study, for example, that it does not include any recording (audio or videotape of the visits). They will not be told if their personal meeting will be monitored and will be assured that all identifying data on pharmaceutical representatives and doctors will be kept strictly confidential.

We will also be expecting you to collect all research articles and printed material (e.g. pamphlets, detailing card) for further investigation.

All information collected as part of the study will be retained for seven years. Information will be kept electronically and also in hand-written notes. All records containing personal information will remain confidential and no information which could lead to identification of any individual will be released.

Please do not hesitate to contact me if you need any further information.

Yours sincerely,

(I've got to say, it sounds like a lot of work for them for no return! Perhaps you should include a little information on how long you would expect each evaluation to take, as if they are imagining an hour-long form each time, they won't want to take part).
You are right. I have overlooked the information on the duration for each evaluation. Thanks again.

Regards,

Fizzi